FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064731490> ?p ?o ?g. }

• W2064731490 abstract "Management of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) requires careful thought so that the most appropriate treatment can be targeted to each individual patient. Initial choices in the management of LUTS/BPH include watchful waiting, medical therapies and surgical interventions. A decision on treatment choice should be taken together with the patient. It should be based on the best available scientific evidence but also be individualised to patients' circumstances and personal choices. Management of LUTS/BPH should be focused on the burden and impact of urinary symptoms and related quality of life. The rate of treatment failure, which can be assessed through the switch to other medical therapy or surgery and/or the delay or prevention of complications related to LUTS/BPH, is also important. Beneficial effects of treatment should be balanced against the incidence of adverse events associated with therapy. Medical therapy has been shown to be effective in improving short-term outcomes (maximum urinary flow rate and symptom scores). Increasing evidence indicates that in the long-term more selective alpha(1)-adrenoceptor (AR) antagonists such as alfuzosin and tamsulosin may reduce the risk of treatment failure with a comparable rate to finasteride. Although the different alpha(1)-AR antagonists are equivalent in efficacy they differ in tolerability with the subtype selective tamsulosin having the lowest risk for interference with blood pressure regulation. Transurethral resection of the prostate (TURP) improves storage symptoms to a lesser extent and/or more slowly than it improves voiding symptoms. In contrast, alpha(1)-AR antagonists improve both voiding and bothersome storage symptoms to the same extent and quite rapidly which has a considerable impact on quality of life. alpha(1)-AR antagonists also relieve storage symptoms to almost the same extent as TURP. Ultimately the initial choice of treatment will depend upon its efficacy, speed of onset, durability, tolerability and on patients' choice. For the majority of patients with moderate to severe symptoms a subtype selective alpha(1)-AR antagonist such as tamsulosin offers the best current combination of efficacy and tolerability." @default.
• W2064731490 created "2016-06-24" @default.
• W2064731490 creator A5017093341 @default.
• W2064731490 date "2001-01-01" @default.
• W2064731490 modified "2023-09-27" @default.
• W2064731490 title "Initial Choices and Final Outcomes in Lower Urinary Tract Symptoms" @default.
• W2064731490 cites W113813005 @default.
• W2064731490 cites W150183739 @default.
• W2064731490 cites W1511185987 @default.
• W2064731490 cites W1681253278 @default.
• W2064731490 cites W1853257794 @default.
• W2064731490 cites W1863847108 @default.
• W2064731490 cites W1966345715 @default.
• W2064731490 cites W1976751461 @default.
• W2064731490 cites W1977090642 @default.
• W2064731490 cites W1983753228 @default.
• W2064731490 cites W1992713768 @default.
• W2064731490 cites W1993811047 @default.
• W2064731490 cites W1994080020 @default.
• W2064731490 cites W1995420224 @default.
• W2064731490 cites W2002004951 @default.
• W2064731490 cites W2004823891 @default.
• W2064731490 cites W2006100624 @default.
• W2064731490 cites W2009440132 @default.
• W2064731490 cites W2010260774 @default.
• W2064731490 cites W2011962188 @default.
• W2064731490 cites W2013156532 @default.
• W2064731490 cites W2026238971 @default.
• W2064731490 cites W2032479436 @default.
• W2064731490 cites W2033346597 @default.
• W2064731490 cites W2038195518 @default.
• W2064731490 cites W2046660139 @default.
• W2064731490 cites W2049518269 @default.
• W2064731490 cites W2056918722 @default.
• W2064731490 cites W2057067784 @default.
• W2064731490 cites W2057812139 @default.
• W2064731490 cites W2057942596 @default.
• W2064731490 cites W2059733087 @default.
• W2064731490 cites W2062527664 @default.
• W2064731490 cites W2071245932 @default.
• W2064731490 cites W2074011745 @default.
• W2064731490 cites W2077358279 @default.
• W2064731490 cites W2080476531 @default.
• W2064731490 cites W2082561935 @default.
• W2064731490 cites W2086325896 @default.
• W2064731490 cites W2088509391 @default.
• W2064731490 cites W2088697451 @default.
• W2064731490 cites W2089377502 @default.
• W2064731490 cites W2090839011 @default.
• W2064731490 cites W2091736229 @default.
• W2064731490 cites W2092719712 @default.
• W2064731490 cites W2093020510 @default.
• W2064731490 cites W2101665942 @default.
• W2064731490 cites W2108409745 @default.
• W2064731490 cites W2115146989 @default.
• W2064731490 cites W2131430938 @default.
• W2064731490 cites W2135421268 @default.
• W2064731490 cites W2137012067 @default.
• W2064731490 cites W2155701228 @default.
• W2064731490 cites W2164294914 @default.
• W2064731490 cites W2319251935 @default.
• W2064731490 cites W2331302678 @default.
• W2064731490 cites W2400484695 @default.
• W2064731490 cites W2408795066 @default.
• W2064731490 cites W2804551733 @default.
• W2064731490 cites W2887836234 @default.
• W2064731490 cites W2980705727 @default.
• W2064731490 cites W2993539218 @default.
• W2064731490 cites W41382664 @default.
• W2064731490 cites W82653403 @default.
• W2064731490 cites W22072688 @default.
• W2064731490 cites W2522655262 @default.
• W2064731490 doi "https://doi.org/10.1159/000049891" @default.
• W2064731490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11786676" @default.
• W2064731490 hasPublicationYear "2001" @default.
• W2064731490 type Work @default.
• W2064731490 sameAs 2064731490 @default.
• W2064731490 citedByCount "16" @default.
• W2064731490 countsByYear W20647314902016 @default.
• W2064731490 countsByYear W20647314902018 @default.
• W2064731490 crossrefType "journal-article" @default.
• W2064731490 hasAuthorship W2064731490A5017093341 @default.
• W2064731490 hasConcept C121608353 @default.
• W2064731490 hasConcept C126322002 @default.
• W2064731490 hasConcept C126894567 @default.
• W2064731490 hasConcept C177713679 @default.
• W2064731490 hasConcept C2776235491 @default.
• W2064731490 hasConcept C2779478474 @default.
• W2064731490 hasConcept C71924100 @default.
• W2064731490 hasConcept C77411442 @default.
• W2064731490 hasConceptScore W2064731490C121608353 @default.
• W2064731490 hasConceptScore W2064731490C126322002 @default.
• W2064731490 hasConceptScore W2064731490C126894567 @default.
• W2064731490 hasConceptScore W2064731490C177713679 @default.
• W2064731490 hasConceptScore W2064731490C2776235491 @default.
• W2064731490 hasConceptScore W2064731490C2779478474 @default.
• W2064731490 hasConceptScore W2064731490C71924100 @default.
• W2064731490 hasConceptScore W2064731490C77411442 @default.
• W2064731490 hasLocation W20647314901 @default.
• W2064731490 hasLocation W20647314902 @default.

• next